Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Socio-Demographic Characteristics of Covid-19 Vaccine Recipients in Kwara State, North Central Nigeria

Bibliographic Data

ID22079644
AuthorsAhmad Ibrahim Al-Mustapha (Université de Tours, corresponding author), Musa Imam Abubakar (Federal Ministry of Agriculture and Rural Development), Muftau Oyewo (Federal Ministry of Agriculture and Rural Development), Rita Enyam Esighetti, Oluwaseun Adeolu Ogundijo (0000-0002-7888-8279, University of Ibadan), Lukman Dele Bolanle, Oluwatosin Enoch Fakayode, Abdullateef Saliman Olugbon (Federal Ministry of Agriculture and Rural Development), Michael Oguntoye (National Primary Health Care Development Agency), Nusirat Elelu (0000-0003-1255-4572, University of Ilorin)
Year2022
Volume9
Pages773998-773998
Publication date2022-01-05
Open AccessYes
TypeARTICLE
VenueFrontiers in Public Health (JOURNAL)
Journal identifiersISSN: 2296-2565 • E-ISSN: 2296-2565
PublisherFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2021.773998
PMID35071159
OpenAlexW4206068358
LanguageEN
Citations received2
References cited26

Understanding key socio-demographic variables of 2019 coronavirus disease (COVID-19) vaccine recipients is crucial to improving its acceptance and Nigeria's COVID-19 control strategy. The survey was conducted as a non-probability cross-sectional survey of 2,936 COVID-19 vaccine recipients in Kwara State. Our findings revealed that 74% ( n = 2,161) of the vaccine recipients were older than 40 years. Forty percent ( n = 1,180) of the vaccine recipients earned a monthly income >100,000 Naira (equivalent to US $200). Most of the vaccine recipients (64%, n = 1,880) had tertiary education, while 15% ( n = 440) of them had no formal education. Almost half of the recipients (47%, n = 1,262) were government employees and 28.8% ( n = 846) of them had health-related backgrounds. Only 17% ( n = 499) of the vaccine recipients have been screened for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), of which 21% ( n = 105/499) of them were tested positive. Only 47% ( n = 1,378) had been fully immunized. The prevalence of confirmed COVID-19 cases among COVID-19 vaccine recipients in Kwara State was 3.6% ( n = 105/2,936). The most recurrent adverse events following immunization (AEFIs) among vaccine recipients were fever (14%, n = 411), pain at injection site (47%, n = 1,409), headache (19%, n = 558), and body weakness (9%, n = 264). The need to protect themselves from the deadly virus was the main reason that prompted people to voluntarily accept the COVID-19 vaccine. There is a high level of COVID-19 vaccine acceptance among respondents across all social classes including those with no formal education, those with very low monthly income (< US $2 per day), and in untested population. Hence, vaccine donors should prioritize equitable distribution to Low-and-Middle-income Countries (LMICs) such as Nigeria, and health authorities should improve vaccine advocacy to focus on vaccine safety and efficacy

Adverse effect · Coronavirus · Disease · Immunization · Immunization program · Vaccination · COVID-19 Impact on Reproduction · SARS-CoV-2 and COVID-19 Research · Vaccine Coverage and Hesitancy

  • A cross-sectional survey of Covid-19 testing status among vaccine recipients in Gombe State, North-Eastern Nigeria

    Open Access•Nafisah Ayinde Sikiru, Ahmad I Al-Mustapha et al.•BMC Public Health•2025

  • Low Covid-19 vaccine uptake in people living with HIV and those with hypertension and diabetes without HIV at Mbarara and Masaka regional referral hospitals

    Open Access•Asiphas Owaraganise, Brian Beesiga et al.•PLOS Global Public Health•2024

  • Improving immunisation coverage in rural India

    Open Access•Abhijit Banerjee, A V Banerjee et al.•BMJ•2010

  • Estimating the effects of non-pharmaceutical interventions on Covid-19 in Europe

    Open Access•Seymour Flaxman, Seth Flaxman et al.•Nature•2020

  • Factors Associated With US Adults’ Likelihood of Accepting Covid-19 Vaccination

    Open Access•Sarah E Krep, Sarah Kreps et al.•JAMA Network Open•2020

  • Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against Sars-CoV-2

    Open Access•Merryn Voysey, Sue Ann Costa Clemens et al.•The Lancet•2021

  • Vaccine hesitancy

    Open Access•Amiel A Dror, Netanel Eisenbach et al.•European Journal of Epidemiology•2020

  • Determinants of Covid-19 vaccine acceptance in the US

    Open Access•Amyn A Malik, SarahAnn M McFadden et al.•EClinicalMedicine•2020

  • Beyond confidence

    Open Access•Cornelia Betsch, Peter Schmid et al.•PLoS ONE•2018

  • Effect of non-pharmaceutical interventions to contain Covid-19 in China

    Open Access•Shengjie Lai, Nick Ruktanonchai et al.•Nature•2020

  • Understanding vaccine hesitancy around vaccines and vaccination from a global perspective

    Heidi J Larson, Caitlin Jarrett et al.•Vaccine•2014

  • A global survey of potential acceptance of a Covid-19 vaccine

    Open Access•Jeffrey V Lazarus, Scott C Ratzan et al.•Nature Medicine•2021

  • Attitudes Toward a Potential Sars-CoV-2 Vaccine

    Kimberly A Fisher, Sarah J Bloomstone et al.•Annals of Internal Medicine•2020

  • Nigeria’s race to zero Covid-19 cases

    Open Access•Ahmad I Al-Mustapha, Abubakar Ahmed Tijani et al.•Journal of Global Health•2021

Citations per year1
Citation span2024 - 2025 (2)
Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae